Track Glenmark Pharmaceuticals Limited's goodwill ($850M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Glenmark Pharmaceuticals Limited (GLENMARK.NS) currently reports a goodwill of $850M as of September 2026. That compares with $810M in the prior-year period — up 5.0% year over year. Use the charts on this page to explore Glenmark Pharmaceuticals Limited's goodwill history and peer comparisons.
Glenmark Pharmaceuticals Limited's goodwill increased from $810M to $850M — a 5.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Glenmark Pharmaceuticals Limited reported $850M in goodwill as of September 2026. That compares with $810M in the prior-year period — up 5.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current goodwill of $850M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Glenmark Pharmaceuticals Limited, and consider following GLENMARK.NS for alerts when major investors trade the stock.